Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Required disclosures for dietary supplements and medication; gluten disclaimer. Requires any person who manufactures, distributes, or sells or offers for sale a dietary supplement to label such dietary supplement with a list of active and inactive ingredients and include a separate disclaimer if the product contains gluten. The bill requires pharmacists, when dispensing a prescription drug, to provide all information required under federal law to accompany the drug, including the medication guide, patient package insert, or other written patient information. The bill also requires pharmacists to provide counseling consistent with federally required labels to patients upon request when dispensing a nonprescription drug. The bill has a delayed effective date of July 1, 2027.
Introduced
Jan 13, 2026
Last Action
Feb 26, 2026
Session
VA 2026
Sponsors
1 primary · 0 co
Subcommittee recommends continuing to (Voice Vote)
Assigned sub: Social Services
Referred to Committee on Health and Human Services
Placed on Calendar
Read first time
Read third time and passed Senate (40-Y 0-N 0-A)
Fiscal Impact Statement from Department of Planning and Budget (SB486)
Read second time
Finance and Appropriations Substitute agreed to
Engrossed by Senate - committee substitute Block Vote (Voice Vote)
Passed by for the day
Committee substitute printed 26107162D-S1
Rules suspended
Constitutional reading dispensed Block Vote (on 1st reading) (40-Y 0-N 0-A)
Passed by for the day (Voice Vote)
Reported from Finance and Appropriations with substitute (15-Y 0-N)
Senate committee offered
Fiscal Impact Statement from Department of Planning and Budget (SB486)
Reported from Education and Health and rereferred to Finance and Appropriations (15-Y 0-N)
Assigned Education sub: Health
Prefiled and ordered printed; Offered 01-14-2026 26105005D
Referred to Committee on Education and Health
Get a plain-English explanation of what this bill does, who it affects, and why it matters.
Subcommittee recommends continuing to (Voice Vote)
Richard H. Stuart